Researcher.Life Logo

Diabetes Technology and Therapeutics : Impact Factor & More

eISSN: 1557-8593pISSN: 1520-9156

Key Metrics

CiteScore
10.3
Eigenfactor
0.005 - 0.01
H-Index
97
Impact Factor
5 - 10
SJR
Q1Endocrinology
SNIP
1.97
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Diabetes Technology and Therapeutics

Diabetes Technology and Therapeutics Journal Specifications

Overview
Publisher MARY ANN LIEBERT, INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1999
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Diabetes Technology and Therapeutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Diabetes Technology and Therapeutics

Glycemic Outcomes and Device Engagement Over 18 Months Following Initiation of Two Different Automated Insulin Delivery Systems in American Youth With Type 1 Diabetes.
  • 20 May 2026
  • Diabetes technology & therapeutics
Real-World Total Daily Insulin Dose in over 14,000 Young Individuals with Type 1 Diabetes in the United States.
  • 12 May 2026
  • Diabetes technology & therapeutics
Real-World Ketone Testing Patterns Among People Using FreeStyle Libre.
  • 11 May 2026
  • Diabetes technology & therapeutics
Cardiovascular, Renal, and Hepatic Biomarkers Outside Guideline-Recommended Thresholds: Prevalence and Determinants in Type 1 Diabetes.
  • 7 May 2026
  • Diabetes technology & therapeutics
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.
  • 28 Apr 2026
  • Diabetes technology & therapeutics
Operational and Clinical Insights from a Fully Decentralized Clinical Study Evaluating Protocol Adherence, Participant Satisfaction, and Connected Device Data in Individuals with Type 2 Diabetes on Different Treatment Regimens.
  • 17 Apr 2026
  • Diabetes technology & therapeutics
Glycemic Outcomes and Device Engagement Over 18 Months Following Initiation of Two Different Automated Insulin Delivery Systems in American Youth With Type 1 Diabetes.
  • 20 May 2026
  • Diabetes technology & therapeutics
Real-World Total Daily Insulin Dose in over 14,000 Young Individuals with Type 1 Diabetes in the United States.
  • 12 May 2026
  • Diabetes technology & therapeutics
Real-World Ketone Testing Patterns Among People Using FreeStyle Libre.
  • 11 May 2026
  • Diabetes technology & therapeutics
Cardiovascular, Renal, and Hepatic Biomarkers Outside Guideline-Recommended Thresholds: Prevalence and Determinants in Type 1 Diabetes.
  • 7 May 2026
  • Diabetes technology & therapeutics
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.
  • 28 Apr 2026
  • Diabetes technology & therapeutics
Operational and Clinical Insights from a Fully Decentralized Clinical Study Evaluating Protocol Adherence, Participant Satisfaction, and Connected Device Data in Individuals with Type 2 Diabetes on Different Treatment Regimens.
  • 17 Apr 2026
  • Diabetes technology & therapeutics

FAQs on Diabetes Technology and Therapeutics